Kaitlin Campbell
Adult Health · New York, NYNPI 1932793072
Payments from drug & device makers
Across 75 payments — averaging $46.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- F. Hoffmann-la Roche AG$2K
- Eisai Inc.$311
- Merck$264
- Ipsen Biopharmaceuticals, Inc$244
- Daiichi Sankyo Inc.$229
- AbbVie$113
- plus $666 from 16 others
What the payments were for
- Travel & lodging$95728%
- Food & beverage$2,39369%
- Education$993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| F. Hoffmann-la Roche AG | 4 | $1,623 |
| Eisai Inc. | 14 | $311 |
| Merck | 11 | $264 |
| Ipsen Biopharmaceuticals, Inc | 9 | $244 |
| Daiichi Sankyo Inc. | 6 | $229 |
| AbbVie | 5 | $113 |
| Tersera Therapeutics LLC | 3 | $88 |
| Novartis | 3 | $86 |
| Bayer | 3 | $73 |
| E.r. Squibb & Sons, L.L.C. | 3 | $59 |
| Immunocore Limited | 2 | $53 |
| Foundation Medicine, Inc. | 2 | $37 |
| Rigel Pharmaceuticals, Inc. | 1 | $34 |
| Amgen | 1 | $29 |
| Pharmaand GmbH | 1 | $28 |
| Tolmar, Inc. | 1 | $28 |
| GSK | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Springworks Therapeutics, Inc. | 1 | $27 |
| AstraZeneca | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Incyte Corporation | 1 | $20 |
How this compares
$3,450 in reported general payments places this provider in the 85th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 32 | $44,746 |
| EliquisApixaban | 15 | $10,477 |
| Dexamethasone | 11 | $242 |
| Oxycodone Hcl | 18 | $220 |
| Ondansetron Hcl | 27 | $167 |
| Zolpidem Tartrate | 12 | $104 |
| ClopidogrelClopidogrel Bisulfate | 13 | $69 |
| Metoclopramide Hcl | 11 | $45 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon | $113 | $44,74632 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,828 adult health providers in New York.
Other adult health in New York
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Alyson HartyNew York$65K
- Laura GraaflandNew York$51K
- Allysa SaggeseNew York$49K
- Juliet EscalonNew York$46K
- Teshmanie RampersaudNew York$23K
- Jenna WenzelNew York$22K
- Elizabeth SavageNew York$20K
- Libby LevineNew York$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.